MDM2 and prostate carcinoma: USP2a was previously shown to be a regulator of the MDM2/p53 pathway in a range of tumor cells, including oral squamous cell carcinoma, testicular embryonal carcinoma, prostate carcinoma, and breast carcinoma [44]–[46].